News Focus
News Focus
Followers 119
Posts 9723
Boards Moderated 0
Alias Born 02/03/2018

Re: HinduKush post# 297378

Tuesday, 09/08/2020 11:41:39 AM

Tuesday, September 08, 2020 11:41:39 AM

Post# of 447455
HDK, The DC court agreed that >500 was a chronic condition to be treated chronically. It did't buy into the Generics claim that Doctors would recommend treatment for only 12 weeks. So Amarin won on infringement. and in the same breath lost on obviousness. Amarin tried to introduce Reduce-it as an extension of Marine, but Du ruled, that since Generics had submitted their ANDA prior to Reduce-it top line, Reduce-it wasn't relevant for the case before the court.

In other words, if you believe Generics would infringe on Reduce-it patents going forward, Amarin is welcome to file a new infringement claim for infringing on the entire Reduce-it data set. I believe HDG confirmed the DC court's ruling on infringement on Marine patents, but moot by invalidating them.

ILT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News